Formula Pharmaceuticals

Formula Pharmaceuticals, Inc. is a private, oncology-focused company developing unique chimeric antigen receptor (“CAR”) immunotherapies to address critical unmet medical needs in cancer. Unlike existing CAR-T approaches, Formula utilizes allogeneic sources, non-viral transfection, and differentiated immune effector cells known as cytokine-induced killer (CIK) cells. Formula has assembled a world-class team of scientific, clinical development, and business professionals capable of maximizing the clinical and commercial value of promising drug candidates through excellence in drug development and strategic partnerships.